Dynatronics (NASDAQ:DYNT) and CELLECT BIOTECH/S (NASDAQ:APOP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.

Profitability

This table compares Dynatronics and CELLECT BIOTECH/S’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics -2.49% -8.09% -1.78%
CELLECT BIOTECH/S N/A -93.06% -60.94%

Risk & Volatility

Dynatronics has a beta of -0.15, suggesting that its stock price is 115% less volatile than the S&P 500. Comparatively, CELLECT BIOTECH/S has a beta of 3.71, suggesting that its stock price is 271% more volatile than the S&P 500.

Institutional & Insider Ownership

11.7% of Dynatronics shares are owned by institutional investors. Comparatively, 3.7% of CELLECT BIOTECH/S shares are owned by institutional investors. 51.8% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Dynatronics and CELLECT BIOTECH/S’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dynatronics $64.42 million 0.37 -$1.60 million ($0.40) -7.33
CELLECT BIOTECH/S N/A N/A -$8.14 million ($1.46) -3.34

Dynatronics has higher revenue and earnings than CELLECT BIOTECH/S. Dynatronics is trading at a lower price-to-earnings ratio than CELLECT BIOTECH/S, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Dynatronics and CELLECT BIOTECH/S, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics 0 0 0 0 N/A
CELLECT BIOTECH/S 0 0 1 0 3.00

CELLECT BIOTECH/S has a consensus price target of $14.00, indicating a potential upside of 187.47%. Given CELLECT BIOTECH/S’s higher possible upside, analysts clearly believe CELLECT BIOTECH/S is more favorable than Dynatronics.

Summary

Dynatronics beats CELLECT BIOTECH/S on 7 of the 12 factors compared between the two stocks.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, distributes, and markets physical medicine products in the United States and internationally. It manufactures and sells electrotherapy, therapeutic ultrasound, phototherapy, thermal therapy, iontophoresis devices, and other modalities; traction therapy equipment; and medical supplies and soft goods, including hot and cold packs, lumbar rolls, exercise balls, wrist splints, ankle weights, cervical collars and pillows, slings, bolsters, positioning wedges, back cushions, weight racks, rehabilitation products, back and wrist braces. The company also sells mat platforms, and other rehabilitation and athletic training room products. In addition, it distributes additional exercise equipment, treatment tables, parallel bars, hand therapy products, hot and cold therapy products, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, walkers, treadmills, stair climbers, heating units for hot packs, whirlpools, electrodes, hydrotherapy and aquatic exercise products, clinical supplies, diagnostic and evaluation products, orthopedic supports, patient positioners, rehabilitation equipment, traction equipment, wound and edema care products, nutritional supplements, and portable electrotherapy products. The company sells its products to licensed practitioners, such as physical therapists, chiropractors, athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics through direct sales representatives and independent dealers, as well as through its e-commerce Websites and product catalogs. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

CELLECT BIOTECH/S Company Profile

Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel. It is developing the Apotainer selection kit, a shelf stem cell selection kit, based on its Powered by Cellect technology platform for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company was founded in 2011 and is headquartered in Kfar Saba, Israel.

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.